Use the link below to get our new mobile app. Thank you for your patience during this transition. We are currently offering COVID-19, flu and RSV vaccines.
GLP-1 Medications May Increase the Risk of Severe Acid Reflux
A new study finds patients with type 2 diabetes who take GLP-1 receptor agonists are 27% more likely to develop gastroesophageal reflux disease (GERD) compared to those taking other common drugs called SGLT-2 inhibitors.
El servicio de noticias de salud es un servicio para los usuarios de la página web de Drug World Pharmacy gracias a HealthDay. Drug World Pharmacy ni sus empleados, agentes, o contratistas, revisan, controlan, o toman responsabilidad por el contenido de los artículos. Por favor busque consejo médico directamente de un farmacéutico o de su médico principal.